Tenecteplase: Clinical Trials

3 trials of Tenecteplase, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 terminated. 3 Phase 2, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 23Terminated 3
Phase 31Terminated 1

Follow Tenecteplase: new trials by email Literature Review of Tenecteplase trials Research Report on Tenecteplase

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Tenecteplase (TNK) for Loculated Pleural Effusions in Patients With Malignancy
normal saline, TNK (Tenecteplase) - Pleural Effusion
Phase 2 / Phase 3TerminatedKaiser Permanente202008-01-012026-04-14
Study of Tenecteplase (TNK) in Acute Ischemic Stroke (TNK-S2B)
tenecteplase, tissue plasminogen activator, tPA - Stroke
Phase 2TerminatedUniversity of Virginia1122005-11-012015-03-17
Tenecteplase Pulmonary Embolism Italian Study
tenecteplase - Pulmonary Embolism
Phase 2TerminatedUniversity Of Perugia1802004-07-012008-05-06

Conditions studied

Ischemia (1)  ·  Neoplasms (1)  ·  Pleural Effusion (1)  ·  Pulmonary Embolism (1)  ·  Stroke (1)  ·  Ventricular Dysfunction, Right (1)

Sponsors

Kaiser Permanente (1)  ·  University Of Perugia (1)  ·  University of Virginia (1)

Countries

United States (2)  ·  Italy (1)

Top investigators

Cecilia Becattini, MD (1)  ·  E. Clarke Haley, Jr., M.D. (1)  ·  Giancarlo Agnelli, MD (1)  ·  Hyo-Chun Yoon, MD (1)  ·  John L. P. Thompson, Ph.D. (1)

Results publications

PMID 19833379, PMID 20185783

NIH funding

R01NS037666 (1), R01NS045170 (1)